{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:49:18Z","timestamp":1794278958107,"version":"4.9.0"},"reference-count":181,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360240"],"award-info":[{"award-number":["82360240"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Frontiers in Neuroendocrinology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.yfrne.2026.101247","type":"journal-article","created":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T22:56:49Z","timestamp":1774220209000},"page":"101247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The microbiota-gut-brain axis in Huntington\u2019s disease: Evidence, mechanisms and therapeutic opportunities"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9869-9830","authenticated-orcid":false,"given":"Yuxiu","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yfrne.2026.101247_b0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/bs.irn.2025.04.002","article-title":"Microbiota dysbiosis impact on the immune system dysregulation in Huntington's disease (HD)","volume":"180","author":"Acharjee","year":"2025","journal-title":"Int. Rev. Neurobiol."},{"issue":"6","key":"10.1016\/j.yfrne.2026.101247_b0010","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","article-title":"Gut microbiota regulation of tryptophan metabolism in health and disease","volume":"23","author":"Agus","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.yfrne.2026.101247_b0015","article-title":"The gut-brain axis: role of gut microbiota in neurological disease pathogenesis and pharmacotherapeutics","author":"Aijaz","year":"2025","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"10","key":"10.1016\/j.yfrne.2026.101247_b0020","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s11095-007-9289-1","article-title":"Bile acid transporters: structure, function, regulation and pathophysiological implications","volume":"24","author":"Alrefai","year":"2007","journal-title":"Pharm. Res."},{"issue":"9","key":"10.1016\/j.yfrne.2026.101247_b0025","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1194\/jlr.R900011-JLR200","article-title":"Bile acids: regulation of apoptosis by ursodeoxycholic acid","volume":"50","author":"Amaral","year":"2009","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.yfrne.2026.101247_b0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tem.2021.11.005","article-title":"Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson's disease","volume":"33","author":"Anis","year":"2021","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.yfrne.2026.101247_b0035","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archneur.65.4.482","article-title":"Rapid eye movement sleep disturbances in Huntington disease","volume":"65","author":"Arnulf","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.yfrne.2026.101247_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102515","article-title":"Microglia and gut microbiota: a double-edged sword in Alzheimer's disease","volume":"101","author":"Bano","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"12","key":"10.1016\/j.yfrne.2026.101247_b0045","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1038\/gim.2014.146","article-title":"American college of medical genetics and genomics standards and guidelines for clinical genetics laboratories, 2014 edition: technical standards and guidelines for Huntington disease","volume":"16","author":"Bean","year":"2014","journal-title":"Genet. Med."},{"issue":"4","key":"10.1016\/j.yfrne.2026.101247_b0050","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/01.MIB.0000209789.14114.63","article-title":"Unique dietary-related mouse model of colitis","volume":"12","author":"Bernstein","year":"2006","journal-title":"Inflamm. Bowel Dis."},{"issue":"9","key":"10.1016\/j.yfrne.2026.101247_b0055","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1111\/febs.15571","article-title":"Microbiota modulation as preventative and therapeutic approach in Alzheimer's disease","volume":"288","author":"Bonfili","year":"2020","journal-title":"FEBS J."},{"issue":"19","key":"10.1016\/j.yfrne.2026.101247_b0060","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1073\/pnas.1604453113","article-title":"Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites","volume":"113","author":"Breda","year":"2016","journal-title":"PNAS"},{"issue":"11","key":"10.1016\/j.yfrne.2026.101247_b0065","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1210\/en.2015-1321","article-title":"Bile acids trigger GLP-1 release predominantly by accessing basolaterally located G protein-coupled bile acid receptors","volume":"156","author":"Brighton","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.yfrne.2026.101247_b0070","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3389\/fnins.2015.00413","article-title":"Role of central vagal 5-HT3 receptors in gastrointestinal physiology and pathophysiology","volume":"9","author":"Browning","year":"2015","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.yfrne.2026.101247_b0075","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1900\/RDS.2011.8.418","article-title":"GLP-1, the gut-brain, and brain-periphery axes","volume":"8","author":"Cabou","year":"2011","journal-title":"Rev. Diabet. Stud."},{"issue":"11","key":"10.1016\/j.yfrne.2026.101247_b0080","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cub.2011.04.028","article-title":"The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease","volume":"21","author":"Campesan","year":"2011","journal-title":"Curr. Biol."},{"issue":"41","key":"10.1016\/j.yfrne.2026.101247_b0085","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1295-24.2024","article-title":"Symposium: what does the microbiome tell Us about prevention and treatment of AD\/ADRD?","volume":"44","author":"Capocchi","year":"2024","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.yfrne.2026.101247_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092505","article-title":"GLP-1 analogue liraglutide attenuates mutant huntingtin-induced neurotoxicity by restoration of neuronal insulin signaling","volume":"19","author":"Chang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yfrne.2026.101247_b0095","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuro.2017.01.005","article-title":"Risk factors for the onset and progression of Huntington disease","volume":"61","author":"Chao","year":"2017","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.yfrne.2026.101247_b0100","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s43556-025-00307-1","article-title":"Microbiota-gut-brain axis in neurodegenerative diseases: molecular mechanisms and therapeutic targets","volume":"6","author":"Chen","year":"2025","journal-title":"Mol Biomed"},{"issue":"3","key":"10.1016\/j.yfrne.2026.101247_b0105","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/1568009033481994","article-title":"Short-chain fatty acid inhibitors of histone deacetylases: promising anticancer therapeutics?","volume":"3","author":"Chen","year":"2003","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.yfrne.2026.101247_b0110","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jnutbio.2015.12.001","article-title":"Metabolic disturbances in plasma as biomarkers for Huntington's disease","volume":"31","author":"Cheng","year":"2016","journal-title":"J. Nutr. Biochem."},{"issue":"3","key":"10.1016\/j.yfrne.2026.101247_b0115","doi-asserted-by":"crossref","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","article-title":"Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy","volume":"318","author":"Chiang","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"7","key":"10.1016\/j.yfrne.2026.101247_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/metabo14070394","article-title":"Diagnostic potential of alternations of bile acid profiles in the plasma of patients with Huntington's disease","volume":"14","author":"Chiang","year":"2024","journal-title":"Metabolites"},{"key":"10.1016\/j.yfrne.2026.101247_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2025.115406","article-title":"Neuroprotective and gut health benefits of Ugni molinae in preclinical Huntington's disease models","volume":"393","author":"Cisternas-Olmedo","year":"2025","journal-title":"Exp. Neurol."},{"issue":"6","key":"10.1016\/j.yfrne.2026.101247_b0130","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/mp.2012.77","article-title":"The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner","volume":"18","author":"Clarke","year":"2012","journal-title":"Mol. Psychiatry"},{"issue":"10","key":"10.1016\/j.yfrne.2026.101247_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047240","article-title":"Altered hypothalamic protein expression in a rat model of Huntington's disease","volume":"7","author":"Cong","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.yfrne.2026.101247_b0140","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","article-title":"The Microbiota-Gut-Brain Axis","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiol. Rev."},{"issue":"8","key":"10.1016\/j.yfrne.2026.101247_b0145","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","article-title":"The role of short-chain fatty acids in microbiota-gut-brain communication","volume":"16","author":"Dalile","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.yfrne.2026.101247_b0150","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1194\/jlr.R054114","article-title":"Intestinal transport and metabolism of bile acids","volume":"56","author":"Dawson","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.yfrne.2026.101247_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.562812","article-title":"The Gut Microbiota, Kynurenine Pathway, and Immune System Interaction in the Development of Brain Cancer","volume":"8","author":"Dehhaghi","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"8083","key":"10.1016\/j.yfrne.2026.101247_b0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/d41586-025-03139-9","article-title":"Huntington's disease treated for first time using gene therapy","volume":"646","author":"Dolgin","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.yfrne.2026.101247_b0165","article-title":"Altered gut microbiota related to inflammatory responses in patients with Huntington's disease","volume":"11","author":"Du","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yfrne.2026.101247_b0170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.603594","article-title":"Altered gut microbiota related to inflammatory responses in patients with Huntington's disease","volume":"11","author":"Du","year":"2021","journal-title":"Front. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.yfrne.2026.101247_b0175","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0303-7207(98)00096-3","article-title":"Tissue distribution of rat glucagon receptor and GLP-1 receptor gene expression","volume":"141","author":"Dunphy","year":"1998","journal-title":"Mol. Cell. Endocrinol."},{"issue":"6","key":"10.1016\/j.yfrne.2026.101247_b0180","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/febs.17102","article-title":"The microbiota-gut-brain axis in Huntington's disease: pathogenic mechanisms and therapeutic targets","volume":"292","author":"Ekwudo","year":"2024","journal-title":"FEBS J."},{"key":"10.1016\/j.yfrne.2026.101247_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2025.106074","article-title":"Prebiotics improve motor function, cognition and gut health in a preclinical model of Huntington's disease","volume":"130","author":"Ekwudo","year":"2025","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.yfrne.2026.101247_b0190","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.expneurol.2018.01.001","article-title":"Activation of NPY-Y2 receptors ameliorates disease pathology in the R6\/2 mouse and PC12 cell models of Huntington's disease","volume":"302","author":"Fatoba","year":"2018","journal-title":"Exp. Neurol."},{"issue":"9","key":"10.1016\/j.yfrne.2026.101247_b0195","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70593","article-title":"The microbiota-gut-brain connection: a new horizon in neurological and neuropsychiatric disorders","volume":"31","author":"Faysal","year":"2025","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.yfrne.2026.101247_b0200","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41467-017-02651-5","article-title":"Microbiota derived short chain fatty acids promote histone crotonylation in the colon through histone deacetylases","volume":"9","author":"Fellows","year":"2018","journal-title":"Nat. Commun."},{"issue":"28","key":"10.1016\/j.yfrne.2026.101247_b0205","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice","volume":"23","author":"Ferrante","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.yfrne.2026.101247_b0210","article-title":"The gut microbiome and neuroinflammation in amyotrophic lateral sclerosis? Emerging clinical evidence","volume":"135","author":"Fournier","year":"2018","journal-title":"Neurobiol. Dis."},{"issue":"7813","key":"10.1016\/j.yfrne.2026.101247_b0215","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41586-020-2396-4","article-title":"A metabolic pathway for bile acid dehydroxylation by the gut microbiome","volume":"582","author":"Funabashi","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.yfrne.2026.101247_b0220","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","article-title":"Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease","volume":"280","author":"Gardian","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.yfrne.2026.101247_b0225","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11154-019-09511-1","article-title":"The gut microbiota to the brain axis in the metabolic control","volume":"20","author":"Grasset","year":"2019","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"4","key":"10.1016\/j.yfrne.2026.101247_b0230","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac205","article-title":"Faecal microbiota transplant ameliorates gut dysbiosis and cognitive deficits in Huntington's disease mice","volume":"4","author":"Gubert","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.yfrne.2026.101247_b0235","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bbi.2023.12.023","article-title":"Dietary fibre confers therapeutic effects in a preclinical model of Huntington's disease","volume":"116","author":"Gubert","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.yfrne.2026.101247_b0240","article-title":"Exercise, diet and stress as modulators of gut microbiota: Implications for neurodegenerative diseases","volume":"134","author":"Gubert","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.yfrne.2026.101247_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103687","article-title":"Gene-environment-gut interactions in Huntington's disease mice are associated with environmental modulation of the gut microbiome","volume":"25","author":"Gubert","year":"2022","journal-title":"iScience"},{"issue":"3","key":"10.1016\/j.yfrne.2026.101247_b0250","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.nbd.2004.07.006","article-title":"Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease","volume":"17","author":"Guidetti","year":"2004","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.yfrne.2026.101247_b0255","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1471-4159.2001.00498.x","article-title":"Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection","volume":"78","author":"Guillemin","year":"2001","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.yfrne.2026.101247_b0260","doi-asserted-by":"crossref","DOI":"10.1111\/jne.70085","article-title":"Sleep in neurodegenerative diseases: a focus on melatonin, melanin-concentrating hormone and orexin","volume":"37","author":"Guillot","year":"2025","journal-title":"J. Neuroendocrinol."},{"issue":"11","key":"10.1016\/j.yfrne.2026.101247_b0265","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11112947","article-title":"Quantification of bile acids in cerebrospinal fluid: results of an observational trial","volume":"11","author":"Harnisch","year":"2023","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.yfrne.2026.101247_b0270","doi-asserted-by":"crossref","DOI":"10.3390\/nu12092598","article-title":"TGR5 signaling in hepatic metabolic health","volume":"12","author":"Holter","year":"2020","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.yfrne.2026.101247_b0275","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13111166","article-title":"Tryptophan metabolism and gut microbiota: a novel regulatory axis integrating the microbiome, immunity, and cancer","volume":"13","author":"Hou","year":"2023","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.yfrne.2026.101247_b0280","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/2045-8118-10-32","article-title":"Fibroblast growth factor 19 entry into brain","volume":"10","author":"Hsuchou","year":"2013","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.yfrne.2026.101247_b0285","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.bbi.2024.03.011","article-title":"Corrigendum to \u201cINT-777 attenuates NLRP3-ASC inflammasome-mediated neuroinflammation via TGR5\/cAMP\/PKA signaling pathway after subarachnoid hemorrhage in rats\u201d [Brain Behav. Immun. 91 (2021) 587-600]","volume":"119","author":"Hu","year":"2024","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.yfrne.2026.101247_b0290","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3233\/JAD-131847","article-title":"High prevalence of diabetes mellitus in a five-generation Chinese family with Huntington's disease","volume":"40","author":"Hu","year":"2014","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.yfrne.2026.101247_b0295","doi-asserted-by":"crossref","first-page":"858","DOI":"10.14336\/AD.2022.0916","article-title":"Tryptophan metabolism in central nervous system diseases: pathophysiology and potential therapeutic strategies","volume":"14","author":"Huang","year":"2023","journal-title":"Aging Dis."},{"issue":"2","key":"10.1016\/j.yfrne.2026.101247_b0300","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/01635580701649644","article-title":"Effect of colonic bacterial metabolites on Caco-2 cell paracellular permeability in vitro","volume":"60","author":"Hughes","year":"2008","journal-title":"Nutr. Cancer"},{"issue":"8","key":"10.1016\/j.yfrne.2026.101247_b0305","article-title":"Functional characterization of arylalkylamine N-acetyltransferase, a pivotal gene in antioxidant melatonin biosynthesis from Chlamydomonas reinhardtii","volume":"11","author":"Hwang","year":"2022","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"10.1016\/j.yfrne.2026.101247_b0310","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26031160","article-title":"Interaction of the vagus nerve and serotonin in the gut-brain axis","volume":"26","author":"Hwang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.yfrne.2026.101247_b0315","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-510X(94)00280-2","article-title":"Dysfunction of brain kynurenic acid metabolism in Huntington's disease: focus on kynurenine aminotransferases","volume":"130","author":"Jauch","year":"1995","journal-title":"J. Neurol. Sci."},{"issue":"12","key":"10.1016\/j.yfrne.2026.101247_b0320","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00702-024-02750-w","article-title":"The pathobiology of depression in Huntington's disease: an unresolved puzzle","volume":"131","author":"Jellinger","year":"2024","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"16","key":"10.1016\/j.yfrne.2026.101247_b0325","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241613021","article-title":"From pathogenesis to therapeutics: a review of 150 years of Huntington's disease research","volume":"24","author":"Jiang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.yfrne.2026.101247_b0330","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1113\/JP281727","article-title":"Bile acids, bioactive signalling molecules in interoceptive gut-to-brain communication","volume":"600","author":"Joyce","year":"2022","journal-title":"J. Physiol."},{"issue":"12","key":"10.1016\/j.yfrne.2026.101247_b0335","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/mds.26003","article-title":"Plasma melatonin is reduced in Huntington's disease","volume":"29","author":"Kalliolia","year":"2014","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.yfrne.2026.101247_b0340","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1210\/en.2011-0174","article-title":"Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4","volume":"152","author":"Kanoski","year":"2011","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.yfrne.2026.101247_b0345","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23116046","article-title":"Molecular basis of bile acid-FXR-FGF15\/19 signaling axis","volume":"23","author":"Katafuchi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.yfrne.2026.101247_b0350","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1074\/jbc.M209706200","article-title":"A G protein-coupled receptor responsive to bile acids","volume":"278","author":"Kawamata","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.yfrne.2026.101247_b0355","doi-asserted-by":"crossref","first-page":"10671","DOI":"10.1073\/pnas.162362299","article-title":"Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease","volume":"99","author":"Keene","year":"2002","journal-title":"PNAS"},{"issue":"2","key":"10.1016\/j.yfrne.2026.101247_b0360","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/exnr.2001.7755","article-title":"A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease","volume":"171","author":"Keene","year":"2001","journal-title":"Exp. Neurol."},{"issue":"15","key":"10.1016\/j.yfrne.2026.101247_b0365","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/glia.21049","article-title":"The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain","volume":"58","author":"Keitel","year":"2010","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.yfrne.2026.101247_b0370","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/18796397241301761","article-title":"Lack of evidence for kynurenine pathway dysfunction in Huntington's disease: CSF and plasma analyses from the HDClarity study","volume":"14","author":"Khetarpal","year":"2024","journal-title":"J. Huntingtons Dis."},{"issue":"2","key":"10.1016\/j.yfrne.2026.101247_b0375","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3233\/JHD-240012","article-title":"Gut microbiota as a modifier of Huntington's disease pathogenesis","volume":"13","author":"Khoshnan","year":"2024","journal-title":"J .Huntingtons Dis."},{"issue":"1","key":"10.1016\/j.yfrne.2026.101247_b0380","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10010068","article-title":"Physiological role of bile acids modified by the gut microbiome","volume":"10","author":"Kiriyama","year":"2021","journal-title":"Microorganisms"},{"issue":"6","key":"10.1016\/j.yfrne.2026.101247_b0385","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.yfrne.2026.101247_b0390","article-title":"Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington's disease","volume":"135","author":"Kong","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.yfrne.2026.101247_b0395","article-title":"An integrated metagenomics and metabolomics approach implicates the microbiota-gut-brain axis in the pathogenesis of Huntington's disease","volume":"148","author":"Kong","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"7","key":"10.1016\/j.yfrne.2026.101247_b0400","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26073318","article-title":"Examination of anti-inflammatory effects after propionate supplementation in the R6\/2 mouse model of Huntington's disease","volume":"26","author":"Konig","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.yfrne.2026.101247_b0405","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179487","article-title":"The multifaceted role of serotonin in intestinal homeostasis","volume":"22","author":"Koopman","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yfrne.2026.101247_b0410","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.55911","article-title":"Histone deacetylase knockouts modify transcription, CAG instability and nuclear pathology in Huntington disease mice","volume":"9","author":"Kovalenko","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.yfrne.2026.101247_b0415","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3389\/fnins.2019.00869","article-title":"Roles of neuropeptide Y in neurodegenerative and neuroimmune diseases","volume":"13","author":"Li","year":"2019","journal-title":"Front. Neurosci."},{"issue":"7","key":"10.1016\/j.yfrne.2026.101247_b0420","doi-asserted-by":"crossref","DOI":"10.3390\/nu15071752","article-title":"Dysbiosis of the gut microbiota and kynurenine (Kyn) pathway activity as potential biomarkers in patients with major depressive disorder","volume":"15","author":"Lin","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.yfrne.2026.101247_b0425","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/bs.irn.2022.06.005","article-title":"The microbiota-gut-brain axis in Huntington's disease","volume":"167","author":"Love","year":"2022","journal-title":"Int. Rev. Neurobiol."},{"issue":"5","key":"10.1016\/j.yfrne.2026.101247_b0430","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ntt.2011.07.002","article-title":"On the antioxidant properties of kynurenic acid: free radical scavenging activity and inhibition of oxidative stress","volume":"33","author":"Lugo-Huitron","year":"2011","journal-title":"Neurotoxicol. Teratol."},{"issue":"18","key":"10.1016\/j.yfrne.2026.101247_b0435","doi-asserted-by":"crossref","first-page":"12445","DOI":"10.1021\/acs.jmedchem.2c01149","article-title":"Developing HDAC4-selective protein degraders to investigate the role of HDAC4 in Huntington's disease pathology","volume":"65","author":"Macabuag","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.yfrne.2026.101247_b0440","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.semcdb.2015.03.002","article-title":"The kynurenine pathway and neurodegenerative disease","volume":"40","author":"Maddison","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.yfrne.2026.101247_b0445","article-title":"Revealed: why the fatal Huntington's gene takes so long to cause harm","author":"Mallapaty","year":"2025","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.yfrne.2026.101247_b0450","doi-asserted-by":"crossref","first-page":"e2207","DOI":"10.1038\/cddis.2016.101","article-title":"The hnRNP-Htt axis regulates necrotic cell death induced by transcriptional repression through impaired RNA splicing","volume":"7","author":"Mao","year":"2016","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.yfrne.2026.101247_b0455","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molmet.2013.10.002","article-title":"Central action of FGF19 reduces hypothalamic AGRP\/NPY neuron activity and improves glucose metabolism","volume":"3","author":"Marcelin","year":"2014","journal-title":"Mol. Metab."},{"issue":"5","key":"10.1016\/j.yfrne.2026.101247_b0460","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1210\/en.2016-1839","article-title":"The diverse metabolic roles of peripheral serotonin","volume":"158","author":"Martin","year":"2017","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.yfrne.2026.101247_b0465","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2337\/db08-0799","article-title":"Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington's disease","volume":"58","author":"Martin","year":"2009","journal-title":"Diabetes"},{"issue":"1\u20132","key":"10.1016\/j.yfrne.2026.101247_b0470","first-page":"17","article-title":"FXR signaling in the enterohepatic system","volume":"368","author":"Matsubara","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"issue":"8","key":"10.1016\/j.yfrne.2026.101247_b0475","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrn3071","article-title":"Gut feelings: the emerging biology of gut-brain communication","volume":"12","author":"Mayer","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.yfrne.2026.101247_b0480","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/s41598-023-50553-y","article-title":"An exploratory metabolomic comparison of participants with fast or absent functional progression from 2CARE, a randomized, double-blind clinical trial in Huntington's disease","volume":"14","author":"McGarry","year":"2024","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.yfrne.2026.101247_b0485","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1096\/fj.201600275R","article-title":"Effects of bile acids on neurological function and disease","volume":"30","author":"McMillin","year":"2016","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.yfrne.2026.101247_b0490","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/mdc3.14029","article-title":"Systemic symptoms in Huntington's disease: a comprehensive review","volume":"11","author":"Mehanna","year":"2024","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.yfrne.2026.101247_b0495","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/bs.irn.2022.07.006","article-title":"Microbiome influences on neuro-immune interactions in neurodegenerative disease","volume":"167","author":"Menees","year":"2022","journal-title":"Int. Rev. Neurobiol."},{"issue":"6","key":"10.1016\/j.yfrne.2026.101247_b0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00476","article-title":"Thinking outside the brain: Gut microbiome influence on innate immunity within neurodegenerative disease","volume":"21","author":"Merchak","year":"2024","journal-title":"Neurotherapeutics"},{"issue":"10","key":"10.1016\/j.yfrne.2026.101247_b0505","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.7150\/ijbs.115359","article-title":"Tryptophan metabolism as a target in gut microbiota, ageing and kidney disease","volume":"21","author":"Miao","year":"2025","journal-title":"Int. J. Biol. Sci."},{"issue":"11","key":"10.1016\/j.yfrne.2026.101247_b0510","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001717","article-title":"HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration","volume":"11","author":"Mielcarek","year":"2013","journal-title":"PLoS Biol."},{"issue":"6","key":"10.1016\/j.yfrne.2026.101247_b0515","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8060154","article-title":"Free fatty acid receptors 2 and 3 as microbial metabolite sensors to shape host health: pharmacophysiological view","volume":"8","author":"Mishra","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.yfrne.2026.101247_b0520","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuroscience.2023.02.014","article-title":"Gut microbiota, an additional hallmark of human aging and neurodegeneration","volume":"518","author":"Molinero","year":"2023","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.yfrne.2026.101247_b0525","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12624","article-title":"Increased plasma melatonin in presymptomatic Huntington disease sheep (Ovis aries): Compensatory neuroprotection in a neurodegenerative disease?","volume":"68","author":"Morton","year":"2019","journal-title":"J. Pineal Res."},{"issue":"2","key":"10.1016\/j.yfrne.2026.101247_b0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031080","article-title":"Genetic knock-down of HDAC3 does not modify disease-related phenotypes in a mouse model of Huntington's disease","volume":"7","author":"Moumne","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.yfrne.2026.101247_b0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102843","article-title":"Gut-brain relationship in dementia and Alzheimer's disease: impact on stress and immunity","volume":"111","author":"Mukherjee","year":"2025","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.yfrne.2026.101247_b0540","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12035-025-05474-4","article-title":"The gut-brain axis in Alzheimer's disease: exploring microbial influences and therapeutic strategies","volume":"63","author":"Mustafa","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.yfrne.2026.101247_b0545","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1021\/acs.bioconjchem.8b00048","article-title":"Fluorescence imaging of Huntingtin mRNA knockdown","volume":"29","author":"Oh","year":"2018","journal-title":"Bioconjug. Chem."},{"issue":"17","key":"10.1016\/j.yfrne.2026.101247_b0550","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30173628","article-title":"Microbiota-derived tryptophan metabolite indole-3-propionic acid-emerging role in neuroprotection","volume":"30","author":"Owe-Larsson","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.yfrne.2026.101247_b0555","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fnmol.2019.00258","article-title":"The role of microglia and astrocytes in Huntington's disease","volume":"12","author":"Palpagama","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.yfrne.2026.101247_b0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2015.12.010","article-title":"Selective novel inverse agonists for human GPR43 augment GLP-1 secretion","volume":"771","author":"Park","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yfrne.2026.101247_b0565","article-title":"The indole-brain connection: neuroimmune mechanisms and therapy","volume":"98","author":"Peng","year":"2025","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.yfrne.2026.101247_b0570","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fnbeh.2014.00135","article-title":"Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanisms","volume":"8","author":"Pla","year":"2014","journal-title":"Front. Behav. Neurosci."},{"issue":"1","key":"10.1016\/j.yfrne.2026.101247_b0575","first-page":"55","article-title":"Abnormal glucose tolerance and arginine tolerance tests in Huntington's disease","volume":"23","author":"Podolsky","year":"1977","journal-title":"Gerontology"},{"issue":"1","key":"10.1016\/j.yfrne.2026.101247_b0580","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12035-024-04271-9","article-title":"Multi-omics analysis reveals key gut microbiota and metabolites closely associated with Huntington's disease","volume":"62","author":"Qian","year":"2024","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.yfrne.2026.101247_b0585","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1055\/s-2000-7461","article-title":"Huntington disease in children: genotype-phenotype correlation","volume":"31","author":"Rasmussen","year":"2000","journal-title":"Neuropediatrics"},{"issue":"4","key":"10.1016\/j.yfrne.2026.101247_b0590","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1096\/fj.14-259598","article-title":"Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells","volume":"29","author":"Reigstad","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.yfrne.2026.101247_b0595","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3389\/fmicb.2020.00973","article-title":"An overview on fecal branched short-chain fatty acids along human life and as related with body mass index: associated dietary and anthropometric factors","volume":"11","author":"Rios-Covian","year":"2020","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.yfrne.2026.101247_b0600","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1038\/s41467-018-05470-4","article-title":"Microbial tryptophan catabolites in health and disease","volume":"9","author":"Roager","year":"2018","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.yfrne.2026.101247_b0605","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1073\/pnas.1031632100","article-title":"Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats","volume":"100","author":"Rodrigues","year":"2003","journal-title":"PNAS"},{"issue":"7","key":"10.1016\/j.yfrne.2026.101247_b0610","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1517\/13543784.10.7.1243","article-title":"The therapeutic effects of ursodeoxycholic acid as an anti-apoptotic agent","volume":"10","author":"Rodrigues","year":"2001","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"6","key":"10.1016\/j.yfrne.2026.101247_b0615","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1046\/j.1471-4159.2000.0752368.x","article-title":"Tauroursodeoxycholic acid partially prevents apoptosis induced by 3-nitropropionic acid: evidence for a mitochondrial pathway independent of the permeability transition","volume":"75","author":"Rodrigues","year":"2000","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.yfrne.2026.101247_b0620","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/jnc.15360","article-title":"Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's disease","volume":"158","author":"Rodrigues","year":"2021","journal-title":"J. Neurochem."},{"issue":"17","key":"10.1016\/j.yfrne.2026.101247_b0625","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25179279","article-title":"Emerging roles of bile acids and TGR5 in the central nervous system: molecular functions and therapeutic implications","volume":"25","author":"Romero-Ramirez","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.yfrne.2026.101247_b0630","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/acn3.214","article-title":"A systems-level \u201cmisunderstanding\u201d: the plasma metabolome in Huntington's disease","volume":"2","author":"Rosas","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"6","key":"10.1016\/j.yfrne.2026.101247_b0635","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nm.4106","article-title":"Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor","volume":"22","author":"Rothhammer","year":"2016","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.yfrne.2026.101247_b0640","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3233\/JHD-230576","article-title":"Sleep disorders and circadian disruption in Huntington's disease","volume":"12","author":"Saade-Lemus","year":"2023","journal-title":"J Huntingtons Dis"},{"issue":"6","key":"10.1016\/j.yfrne.2026.101247_b0645","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2174\/1570159X19666211201094608","article-title":"Neuroinflammation in Huntington's disease: a starring role for astrocyte and microglia","volume":"20","author":"Saba","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.yfrne.2026.101247_b0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2025.106276","article-title":"The microbiota-inflammasome-brain axis as a pathogenic mediator of neurodegenerative disorders","volume":"176","author":"Sarkar","year":"2025","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"7","key":"10.1016\/j.yfrne.2026.101247_b0655","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1111\/all.16065","article-title":"Systematic review of the association between short-chain fatty acids and allergic diseases","volume":"79","author":"Sasaki","year":"2024","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.yfrne.2026.101247_b0660","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s13311-019-00805-5","article-title":"Vildagliptin attenuates huntington's disease through activation of GLP-1 receptor\/PI3K\/Akt\/BDNF pathway in 3-nitropropionic acid rat model","volume":"17","author":"Sayed","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"3","key":"10.1016\/j.yfrne.2026.101247_b0665","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41591-024-03424-6","article-title":"Somatic CAG repeat expansion in blood associates with biomarkers of neurodegeneration in Huntington's disease decades before clinical motor diagnosis","volume":"31","author":"Scahill","year":"2025","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.yfrne.2026.101247_b0670","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/febs.17161","article-title":"Gut microbiota in multiple sclerosis and animal models","volume":"292","author":"Schumacher","year":"2024","journal-title":"FEBS J."},{"issue":"7","key":"10.1016\/j.yfrne.2026.101247_b0675","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.yfrne.2026.101247_b0680","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2020.568991","article-title":"Short chain fatty acids enhance expression and activity of the umami taste receptor in enteroendocrine cells via a Galpha(i\/o) pathway","volume":"7","author":"Shackley","year":"2020","journal-title":"Front. Nutr."},{"key":"10.1016\/j.yfrne.2026.101247_b0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121882","article-title":"Gut microbiota dysbiosis and Huntington's disease: Exploring the gut-brain axis and novel microbiota-based interventions","volume":"328","author":"Sharma","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.yfrne.2026.101247_b0690","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fendo.2020.00025","article-title":"The role of short-chain fatty acids from gut microbiota in gut-brain communication","volume":"11","author":"Silva","year":"2020","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"6","key":"10.1016\/j.yfrne.2026.101247_b0695","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s11011-021-00844-y","article-title":"Metabolism in Huntington's disease: a major contributor to pathology","volume":"37","author":"Singh","year":"2021","journal-title":"Metab. Brain Dis."},{"issue":"13","key":"10.1016\/j.yfrne.2026.101247_b0700","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143775","article-title":"Neurodegenerative disorders and gut-brain interactions","volume":"131","author":"Singh","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.yfrne.2026.101247_b0705","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/135502801300069692","article-title":"Quinolinic acid is produced by macrophages stimulated by platelet activating factor","volume":"7","author":"Smith","year":"2001","journal-title":"Nef Tat. J. Neurovirol."},{"issue":"1","key":"10.1016\/j.yfrne.2026.101247_b0710","doi-asserted-by":"crossref","first-page":"18270","DOI":"10.1038\/s41598-020-75229-9","article-title":"Increased intestinal permeability and gut dysbiosis in the R6\/2 mouse model of Huntington's disease","volume":"10","author":"Stan","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.yfrne.2026.101247_b0715","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1471-4159.2005.03070.x","article-title":"Tryptophan metabolism and oxidative stress in patients with Huntington's disease","volume":"93","author":"Stoy","year":"2005","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.yfrne.2026.101247_b0720","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.1038\/s41598-017-05125-2","article-title":"A selective inhibitor of histone deacetylase 3 prevents cognitive deficits and suppresses striatal CAG repeat expansions in Huntington's disease mice","volume":"7","author":"Suelves","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yfrne.2026.101247_b0725","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbi.2022.08.003","article-title":"Microbiota-derived metabolite Indoles induced aryl hydrocarbon receptor activation and inhibited neuroinflammation in APP\/PS1 mice","volume":"106","author":"Sun","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.yfrne.2026.101247_b0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109478","article-title":"Role of microbial dysbiosis in the pathogenesis of Alzheimer's disease","volume":"229","author":"Susmitha","year":"2023","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.yfrne.2026.101247_b0735","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/brain\/awaf419","article-title":"Faecal microbiota transplant for Parkinson's disease: promises and future directions","volume":"149","author":"Tan","year":"2026","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.yfrne.2026.101247_b0740","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-mediated bile acid sensing controls glucose homeostasis","volume":"10","author":"Thomas","year":"2009","journal-title":"Cell Metab."},{"key":"10.1016\/j.yfrne.2026.101247_b0745","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.72171","article-title":"Short-chain fatty acids activate acetyltransferase p300","volume":"10","author":"Thomas","year":"2021","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.yfrne.2026.101247_b0750","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2337\/db11-1019","article-title":"Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2","volume":"61","author":"Tolhurst","year":"2011","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.yfrne.2026.101247_b0755","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nm824","article-title":"PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect","volume":"9","author":"Tunaru","year":"2003","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.yfrne.2026.101247_b0760","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70339","article-title":"The enteric nervous system as a mediator of microbiota-gut-brain interactions in Parkinson's disease","volume":"170","author":"Valdetaro","year":"2026","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.yfrne.2026.101247_b0765","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.tim.2021.02.001","article-title":"Microbial regulation of host physiology by short-chain fatty acids","volume":"29","author":"van der Hee","year":"2021","journal-title":"Trends Microbiol."},{"issue":"6","key":"10.1016\/j.yfrne.2026.101247_b0770","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00415-020-10334-3","article-title":"The sleep and circadian problems of Huntington's disease: when, why and their importance","volume":"268","author":"Voysey","year":"2020","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.yfrne.2026.101247_b0775","doi-asserted-by":"crossref","DOI":"10.3390\/ph11030063","article-title":"Role of microbiota and tryptophan metabolites in the remote effect of intestinal inflammation on brain and depression","volume":"11","author":"Waclawikova","year":"2018","journal-title":"Pharmaceuticals (Basel)"},{"issue":"9","key":"10.1016\/j.yfrne.2026.101247_b0780","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jnutbio.2007.08.002","article-title":"Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon","volume":"19","author":"Waldecker","year":"2007","journal-title":"J. Nutr. Biochem."},{"issue":"1","key":"10.1016\/j.yfrne.2026.101247_b0785","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2025.5687","article-title":"Microbial short chain fatty acids: effective histone deacetylase inhibitors in immune regulation (Review)","volume":"57","author":"Wang","year":"2025","journal-title":"Int. J. Mol. Med."},{"issue":"9","key":"10.1016\/j.yfrne.2026.101247_b0790","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1093\/brain\/awab156","article-title":"The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options","volume":"144","author":"Wang","year":"2021","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.yfrne.2026.101247_b0795","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3233\/JHD-220556","article-title":"A randomized controlled trial of probiotics targeting gut dysbiosis in Huntington's disease","volume":"12","author":"Wasser","year":"2023","journal-title":"J Huntingtons Dis"},{"issue":"2","key":"10.1016\/j.yfrne.2026.101247_b0800","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa110","article-title":"Gut dysbiosis in Huntington's disease: associations among gut microbiota, cognitive performance and clinical outcomes","volume":"2","author":"Wasser","year":"2020","journal-title":"Brain Commun"},{"issue":"7","key":"10.1016\/j.yfrne.2026.101247_b0805","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/cr.2017.68","article-title":"Class I histone deacetylases are major histone decrotonylases: evidence for critical and broad function of histone crotonylation in transcription","volume":"27","author":"Wei","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.yfrne.2026.101247_b0810","article-title":"Gut microbiota, kynurenine pathway and mental disorders - review","volume":"106","author":"Wiedlocha","year":"2020","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.yfrne.2026.101247_b0815","article-title":"The 7-alpha-dehydroxylation pathway: an integral component of gut bacterial bile acid metabolism and potential therapeutic target","volume":"13","author":"Wise","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.yfrne.2026.101247_b0820","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.intimp.2019.03.065","article-title":"Protective effects of tauroursodeoxycholic acid on lipopolysaccharide-induced cognitive impairment and neurotoxicity in mice","volume":"72","author":"Wu","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.yfrne.2026.101247_b0825","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13578-023-01053-z","article-title":"Roles of bile acids signaling in neuromodulation under physiological and pathological conditions","volume":"13","author":"Xing","year":"2023","journal-title":"Cell Biosci."},{"key":"10.1016\/j.yfrne.2026.101247_b0830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2025.07.003","article-title":"Parkinson's disease and the gut microbiota connection: unveiling dysbiosis and exploring therapeutic horizons","volume":"581","author":"Yadav","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.yfrne.2026.101247_b0835","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fnagi.2017.00193","article-title":"Microglial activation in the pathogenesis of Huntington's disease","volume":"9","author":"Yang","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.yfrne.2026.101247_b0840","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1742-2094-11-50","article-title":"Tauroursodeoxycholic acid reduces glial cell activation in an animal model of acute neuroinflammation","volume":"11","author":"Yanguas-Casas","year":"2014","journal-title":"J. Neuroinflammation"},{"issue":"8","key":"10.1016\/j.yfrne.2026.101247_b0845","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1002\/jcp.25742","article-title":"TUDCA: an agonist of the bile acid receptor GPBAR1\/TGR5 with anti-inflammatory effects in microglial cells","volume":"232","author":"Yanguas-Casas","year":"2017","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.yfrne.2026.101247_b0850","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","article-title":"Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis","volume":"161","author":"Yano","year":"2015","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.yfrne.2026.101247_b0855","doi-asserted-by":"crossref","first-page":"839","DOI":"10.18632\/aging.100818","article-title":"Blocking the association of HDAC4 with MAP1S accelerates autophagy clearance of mutant Huntingtin","volume":"7","author":"Yue","year":"2015","journal-title":"Aging (Albany NY)"},{"issue":"12","key":"10.1016\/j.yfrne.2026.101247_b0860","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1182\/bloodadvances.2024015000","article-title":"AhR activation mitigates graft-versus-host disease of the central nervous system by reducing microglial NF-kappaB signaling","volume":"9","author":"Zahringer","year":"2025","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.yfrne.2026.101247_b0865","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","article-title":"Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22","volume":"39","author":"Zelante","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.yfrne.2026.101247_b0870","article-title":"Gut microbiota: an intermediary between metabolic syndrome and cognitive deficits in schizophrenia","volume":"106","author":"Zeng","year":"2020","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.yfrne.2026.101247_b0875","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12964-023-01219-9","article-title":"Short-chain fatty acids in diseases","volume":"21","author":"Zhang","year":"2023","journal-title":"Cell Commun. Signal"},{"issue":"5","key":"10.1016\/j.yfrne.2026.101247_b0880","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2025.5633","article-title":"Role of the gut-brain axis in neurological diseases: molecular connections and therapeutic implications (Review)","volume":"56","author":"Zhang","year":"2025","journal-title":"Int. J. Mol. Med."},{"issue":"21","key":"10.1016\/j.yfrne.2026.101247_b0885","doi-asserted-by":"crossref","first-page":"8320","DOI":"10.1039\/D5FO03139G","article-title":"The intricate microbial-gut-brain axis in Alzheimer's disease: a review of microbiota-targeted strategies","volume":"16","author":"Zhang","year":"2025","journal-title":"Food Funct."},{"key":"10.1016\/j.yfrne.2026.101247_b0890","article-title":"DSS-induced colitis activates the kynurenine pathway in serum and brain by affecting IDO-1 and gut microbiota","volume":"13","author":"Zhao","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.yfrne.2026.101247_b0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00423","article-title":"An emerging role for the gut microbiome in tauopathy","volume":"21","author":"Zhu","year":"2024","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.yfrne.2026.101247_b0900","article-title":"Olanzapine-induced lipid disturbances: a potential mechanism through the gut microbiota-brain axis","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.yfrne.2026.101247_b0905","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","article-title":"Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration","volume":"145","author":"Zwilling","year":"2011","journal-title":"Cell"}],"container-title":["Frontiers in Neuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091302226000178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091302226000178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T08:01:58Z","timestamp":1779868918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091302226000178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":181,"alternative-id":["S0091302226000178"],"URL":"https:\/\/doi.org\/10.1016\/j.yfrne.2026.101247","relation":{},"ISSN":["0091-3022"],"issn-type":[{"value":"0091-3022","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The microbiota-gut-brain axis in Huntington\u2019s disease: Evidence, mechanisms and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Frontiers in Neuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yfrne.2026.101247","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101247"}}